More on ADPT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $15.14 |
|
|||
| Open | $15.05 | ||||
| 52 Wk High | $73.44 | ||||
| 52 Wk Low | $7.91 | ||||
| Day High | $16.00 | ||||
| Day Low | $14.76 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,236,706 | ||||
- At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
- Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
- Form 4 Adaptive Biotechnologies For: May 18 Filed by: PISKEL KYLE
- Form 144 Adaptive Biotechnologies Filed by: PISKEL KYLE
- Form SCHEDULE 13G/A Adaptive Biotechnologies Filed by: VIKING GLOBAL INVESTORS LP
- Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $18 at Morgan Stanley
- Adaptive Biotechnologies Corp. (ADPT) PT Lowered to $19 at JPMorgan
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $21 at TD Cowen
- Form 10-Q Adaptive Biotechnologies For: Mar 31
- Form 8-K Adaptive Biotechnologies For: May 05
Entities mentioned with ADPT
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- Goldman Sachs | View Related Stories »
- JPMorgan | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
